Designation: Professor
Department: Psychiatry & Neurosciences
University: Laval University
Country: Canada
Dr. Guertin has 28 years of experience in spinal cord research and 16 years of experience in science leadership. He was President and CEO of NeuroSpina Therapeutics between 2005 and 2008 as well as Chief Scientific Officer of Eurymedon HealthCare during the same period. He is currently developing next-generation pharmaceutical, healthcare and skincare products for people with CNS trauma, paralysis and mobility impairment due to aging or disease. He holds positions as Full Professor in the Department of Psychiatry & Neurosciences (Université Laval, 2001 - present) as well as Director and Principal Investigator of the Spinal Cord Injury and Functional Recovery Laboratory (2002 – present, Laval University Medical Center, Quebec). As a leading scientist, he is author and co-author of more than many publications (articles, reviews, book chapters, patents, etc.) since 1990.
His research interest focuses on Neurology, Brain and motor skills & Pharmacological methods of reactivation of neurons in the spinal cord locomotor.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
